Thank you.
Every year when we study supplementary estimates, I always have a question for Mr. Beaudet as well.
Could you share with the committee what types of investments we're seeing for neurological disorders? I know that CIHR has had a heavy emphasis on that, which is tremendously reassuring, but maybe you could share with us some of the work that's being undertaken now.